Halozyme Therapeutics, Inc. (HALO) — DEF 14A Filings
All DEF 14A filings from Halozyme Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Halozyme Therapeutics Executive Compensation Revealed
— Mar 18, 2025 Risk: low
Halozyme Therapeutics, Inc. filed its DEF 14A on March 18, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing inclu -
Halozyme Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— Mar 15, 2024 Risk: low
HALOZYME THERAPEUTICS, INC. (HALO) filed a Proxy Statement (DEF 14A) with the SEC on March 15, 2024. The 2024 Annual Meeting of Stockholders for Halozyme Therap
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX